Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury.

Abstract

Limiting the development of secondary damage represents one of the major goals of neuroprotective therapies after spinal cord injury. Here, we demonstrate that specific JNK inhibition via a single intraperitoneal injection of the cell permeable peptide D-JNKI1 6h after lesion improves locomotor recovery assessed by both the footprint and the BMS tests up to 4 months post-injury in mice. JNK inhibition prevents c-jun phosphorylation and caspase-3 cleavage, has neuroprotective effects and results in an increased sparing of white matter at the lesion site. Lastly, D-JNKI1 treated animals show a lower increase of erythrocyte extravasation and blood brain barrier permeability, thus indicating protection of the vascular system. In total, these results clearly point out JNK inhibition as a promising neuroprotective strategy for preventing the evolution of secondary damage after spinal cord injury.

DOI: 10.1016/j.nbd.2012.03.014
05010020132014201520162017
Citations per Year

183 Citations

Semantic Scholar estimates that this publication has 183 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Repici2012SpecificIO, title={Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury.}, author={Mariaelena Repici and Xiaoru Chen and M C Morel and Mohamed Doulazmi and Alessandra Sclip and Vidjeacoumary Cannaya and Pietro Veglianese and Rudolf Kraftsik and Jean Mariani and Tiziana Borsello and Isabelle Dusart}, journal={Neurobiology of disease}, year={2012}, volume={46 3}, pages={710-21} }